Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Ochoa

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myelomaOihana Murillo, Ainhoa Arina, Sandra Hervas-Stubbs, et al.
Plos One|January 4, 2013
Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapyMaria C Ochoa, Jessica Fioravanti, Erwin H Duitman, et al.
Oncoimmunology|May 31, 2019
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cellsMaria C Ochoa, Elisabeth Perez-Ruiz, Luna Minute, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Cellular cytotoxicity is a form of immunogenic cell deathLuna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, et al.
Cancer Research|December 21, 2014
Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12Ignacio Melero, Jose I Quetglas, Mercedes Reboredo, et al.
Cancer Immunology Research|September 28, 2021
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor FunctionMariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia, et al.
Theranostics|February 14, 2022
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagersAlvaro Teijeira, Itziar Migueliz, Saray Garasa, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology|April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimeticMaite Alvarez, Carmen Molina, Saray Garasa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapySandra Hervas-Stubbs, Uxua Mancheño, Jose-Ignacio Riezu-Boj, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myelomaOihana Murillo, Ainhoa Arina, Sandra Hervas-Stubbs, et al.
Plos One|January 4, 2013
Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapyMaria C Ochoa, Jessica Fioravanti, Erwin H Duitman, et al.
Oncoimmunology|May 31, 2019
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cellsMaria C Ochoa, Elisabeth Perez-Ruiz, Luna Minute, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Cellular cytotoxicity is a form of immunogenic cell deathLuna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, et al.
Cancer Research|December 21, 2014
Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12Ignacio Melero, Jose I Quetglas, Mercedes Reboredo, et al.
Cancer Immunology Research|September 28, 2021
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor FunctionMariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia, et al.
Theranostics|February 14, 2022
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagersAlvaro Teijeira, Itziar Migueliz, Saray Garasa, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology|April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimeticMaite Alvarez, Carmen Molina, Saray Garasa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapySandra Hervas-Stubbs, Uxua Mancheño, Jose-Ignacio Riezu-Boj, et al.
Pageof 3